Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV co-infected individuals in Sub-Saharan Africa: results from the HEPIK cohort

被引：0
|
作者：
Villa, Giovanni [1 ]
Phillips, Richard Odame [2 ,3 ]
Smith, Colette [4 ]
Stockdale, Alexander [1 ]
Beloukas, Apostolos [1 ]
Appiah, Lambert Tetteh [2 ,3 ]
Chadwick, David [5 ]
Ruggiero, Alessandra [1 ]
Sarfo, Fred Stephen [2 ,3 ]
Post, Frank [6 ]
Geretti, Anna Maria [1 ]
机构：
[1] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England
[2] Kwame Nkrumah Univ Sci & Technol, Dept Med, Kumasi, Ghana
[3] Komfo Anokye Teaching Hosp, Kumasi, Ghana
[4] UCL, Infect & Populat Hlth, London, England
[5] James Cook Univ Hosp, Ctr Clin Infect, Middlesbrough, Cleveland, England
[6] Kings Coll London, Kings Ctr Global Hlth, London, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P219
引用
收藏
页数：1
相关论文
共 18 条
  • [1] Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana
    Villa, G.
    Phillips, R. O.
    Smith, C.
    Stockdale, A. J.
    Beloukas, A.
    Appiah, L. T.
    Chadwick, D.
    Ruggiero, A.
    Sarfo, F. S.
    Post, F.
    Geretti, A. M.
    JOURNAL OF INFECTION, 2018, 76 (06) : 515 - 521
  • [2] Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting
    Milazzo, Laura
    Gervasoni, Cristina
    Falvella, Felicia Stefania
    Cattaneo, Dario
    Mazzali, Cristina
    Ronzi, Paola
    Binda, Francesca
    Cheli, Stefania
    Sollima, Salvatore
    Antinori, Spinello
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (02): : 191 - 196
  • [3] Long-term (96-week) efficacy and safety after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-infected, virologically suppressed adults
    Raffi, Francois
    Orkin, Chloe
    Clarke, Amanda
    Slama, Laurence
    Gallant, Joel
    Daar, Eric
    Yan, Mingjin
    Abram, Michael E.
    Friborg, Sandra
    Cheng, Andrew
    Rhee, Martin
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [4] Tenofovir disoproxil fumarate (TDF) and adefovir dipivoxil (ADV) are effective in chronic hepatitis B virus (HBV) infection in subjects who are co-infected with HIV: HBV and HIV drug resistance results of ACTG Protocol A5127
    Johnson, V. A.
    Hazelwood, J. D.
    Andersen, J.
    Miller, A. B.
    Liu, T.
    Alston-Smith, B.
    Brosgart, C. L.
    Rooney, J. F.
    Polsky, B.
    Peters, M. G.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S11 - S11
  • [5] Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults
    Agbaji, Oche O.
    Abah, Isaac O.
    Ebonyi, Augustine O.
    Gimba, Zumnan M.
    Abene, Esla E.
    Gomerep, Simji S.
    Falang, Kakjing D.
    Anejo-Okopi, Joseph
    Agaba, Patricia A.
    Ugoagwu, Placid O.
    Agaba, Emmanuel I.
    Imade, Godwin E.
    Sagay, Atiene S.
    Okonkwo, Prosper
    Idoko, John A.
    Kanki, Phyllis J.
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2019, 18
  • [6] Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults
    Raffi, Francois
    Orkin, Chloe
    Clarke, Amanda
    Slama, Laurence
    Gallant, Joel
    Daar, Eric
    Henry, Keith
    Santana-Bagur, Jorge
    Stein, David K.
    Bellos, Nicholaos
    Scarsella, Anthony
    Yan, Mingjin
    Abram, Michael E.
    Cheng, Andrew
    Rhee, Martin S.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 75 (02) : 226 - 231
  • [7] LONG-TERM FOLLOW-UP EVALUATION OF THE EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN A EUROPEAN MULTICENTER (NUCLEOS(T)IDE EXPERIENCED) HEPATITIS B VIRUS HBV-INFECTED COHORT
    van Boemmel, Florian
    De Man, Robert A.
    Ferenci, Peter
    Reijnders, Jurrien G.
    Bronowicki, Jean-Pierre
    Fueloep, Balazs
    Wedemeyer, Heiner
    Erhardt, Andreas
    Hueppe, Dietrich
    Bourliere, Marc
    Sarrazin, Christoph
    Trojan, Jorg
    Buggisch, Peter
    Petersen, Joerg
    Spengler, Ulrich
    Brost, Sylvia
    Pariente, Alexandre
    Schuchmann, Marcus
    Wasmuth, Hermann Elard
    Deterding, Katja
    Rutter, Karoline
    Feucht, Heinz-Hubert
    Wiedenmann, Bertram
    Berg, Thomas
    HEPATOLOGY, 2009, 50 (04) : 409A - 409A
  • [8] SIGNIFICANT LIVER FIBROSIS IS AN INDEPENDENT RISK FACTOR OF RENAL IMPAIRMENT IN HIV-HBV CO-INFECTED PATIENTS TREATED WITH TENOFOVIR (TDF): RESULTS OF A 3-YEAR-COHORT STUDY
    Boyd, Anders
    Bottero, Julie
    Lascoux-combe, Caroline
    Molina, Jean-Michel
    Miailhes, Patrick
    Girard, Pierre-Marie
    Lacombe, Karine
    HEPATOLOGY, 2010, 52 (04) : 513A - 513A
  • [9] Mortality in relation to hepatitis B virus (HBV) infection status among HIV-HBV co-infected patients in sub-Saharan Africa after immediate initiation of antiretroviral therapy
    Mohareb, Amir M.
    Kouame, Gerard Menan
    Gabassi, Audrey
    Gabillard, Delphine
    Moh, Raoul
    Badje, Anani
    Emieme, Arlette
    Maylin, Sarah
    Menan, Herve
    Hyle, Emily P.
    Delaugerre, Constance
    Danel, Christine
    Anglaret, Xavier
    Lacombe, Karine
    Eholie, Serge P.
    Boyd, Anders
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (04) : 621 - 629
  • [10] Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4+ cell counts
    Kouame, Gerard M.
    Gabillard, Delphine
    Moh, Raoul
    Badje, Anani
    Ntakpe, Jean B.
    Emieme, Arlette
    Maylin, Sarah
    Toni, Thomas dAquin
    Menan, Herve
    Zoulim, Fabien
    Danel, Christine
    Anglaret, Xavier
    Eholie, Serge
    Lacombe, Karine
    Boyd, Anders
    ANTIVIRAL THERAPY, 2021, 26 (1-2) : 25 - 33
12